Elelyso

DRUG2 trials

Sponsors

Ari Zimran, Shaare Zedek Medical Center

Conditions

Gaucher Disease, Type 1Gaucher Disease, Type 3

Phase 4

A Multicenter, Safety and Efficacy Study of Taliglucerase Alfa in Subjects With Type 3 Gaucher Disease

CompletedNCT04002830

Ari ZimranGaucher Disease, Type 3

Start: 2020-11-20End: 2023-07-30Updated: 2024-12-17

Unknown Phase

Assessing the Impact of Elelyso on Bone Involvement Currently Treated With Other ERTs

CompletedNCT04353466

Shaare Zedek Medical CenterGaucher Disease, Type 1

Start: 2017-01-01End: 2021-07-31Updated: 2022-10-28